Our results showed, in all the biological fluids analyzed, higher anti-SARS-CoV-2 IgA-S1 and IgG-RBD production in vaccinated subjects in comparison with healthy controls and subjects recovered from previous COVID-19. The gene discussed is CD79A; the disease is COVID-19.